Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Revance Therapeutics, Inc. | COO, President of R&D | Common Stock | 121K | $902K | $7.47 | Mar 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Mar 15, 2022 | 1 | -$41.2K | 4 | Mar 17, 2022 | COO, President of R&D |
RVNC | Revance Therapeutics, Inc. | Feb 15, 2022 | 2 | -$67.5K | 4 | Feb 17, 2022 | COO, President, R&D |